The FDA placed some balloon pumps on its medical device shortage list Dec. 2, which the agency said was because of increased demand and shortage of some of the product’s components. There is a ...
Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction does not reduce the scope of heart muscle damage, a condition referred to as infarct size, ...
The FDA has disclosed over 60 additional safety reports relating to intra-aortic balloon pumps manufactured by Maquet and Datascope, including two patient deaths, following a Class I recall this past ...
A Japanese study of intra-aortic balloon pumps appears to indicate the devices do little to improve outcomes for patients with acute cases and may increase the chances of death. In the registry study ...
Please provide your email address to receive an email when new articles are posted on . Datascope/Maquet/Getinge intra-aortic balloon pumps recalled due to risk for unexpected shutdown. The FDA has ...
LIMERICK, Pa.--(BUSINESS WIRE)-- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced a new agreement with HealthTrust Purchasing ...
Randomized Controlled Trial Results Presented At EuroPCR Demonstrate Advantages Over Uncoated Angioplasty Balloons and Drug-Eluting Stents PARIS – Adding to the growing body of evidence on a novel ...
Aspero Medical has received a patent for new technology that will help physicians diagnose and treat gastrointestinal illness more effectively. The medical device startup, cofounded by Paul M. Rady ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results